Canada Life’s Applied Molecular Transport Inc. Common Stock AMTI Stock Holding History

Canada Life’s Portfolio AMTI Stock Details AMTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-734	Closed	-$6K	–	2477
2022 Q1	$6K	Hold	734	–	–	﹤0.01%	2465
2021 Q4	$10K	Hold	734	–	–	﹤0.01%	2451
2021 Q3	$19K	Hold	734	–	–	﹤0.01%	2447
2021 Q2	$33K	Hold	734	–	–	﹤0.01%	2385
2021 Q1	$32K	Hold	734	–	–	﹤0.01%	2431
2020 Q4	$22K	Buy	+734	New	+$23.3K	﹤0.01%	2525

Other funds holding AMTI

ECG

EPIQ Capital Group San Francisco, California $383M AUM 46.87% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

FFVM

Founders Fund V Management San Francisco, California $2.16M AUM 77.37% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FFVM

Founders Fund VI Management San Francisco, California $45.8K AUM 58.63% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Canada Life's AMTI Position: Q2 2022 in Review

Canada Life sold out of Applied Molecular Transport Inc. Common Stock (AMTI) in Q2 2022, closing a stake of 734 shares — an estimated $6K sold.

Canada Life first reported a position in AMTI in Q4 2020 and held it in 6 quarters. The position peaked at $33K in Q2 2021. 56 funds tracked by Wall St. Rank hold AMTI as of Q2 2022.

Canada Life reported no remaining Applied Molecular Transport Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Canada Life sold 734 Applied Molecular Transport Inc. Common Stock shares in Q2 2022, an estimated $6K.
Canada Life first reported a position in Applied Molecular Transport Inc. Common Stock in Q4 2020 and held it in 6 quarters.
Canada Life's Applied Molecular Transport Inc. Common Stock position peaked at $33K in Q2 2021.
56 funds tracked by Wall St. Rank held Applied Molecular Transport Inc. Common Stock as of Q2 2022.

Based on Canada Life's 13F filing for Q2 2022, filed 9 Aug 2022.